• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pluristem Therapeutics Inc

+ Add to Watchlist

PSTI:IT

980.20 ILs 14.10 1.42%

As of 10:24:36 ET on 11/24/2014.

Snapshot for Pluristem Therapeutics Inc (PSTI)

Open: 990.20 Day's Range: 976.00 - 990.20 Volume: 88,405
Previous Close: 994.30 52wk Range: 909.10 - 1,695.00 1-Yr Rtn: -15.13%

Stock Chart for PSTI

No chart data available.
  • PSTI:IT 976.00
  • 1D
  • 1M
  • 1Y
994.30
Interactive PSTI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PSTI

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. TA-100 -
Earnings Per Share (USD) (ttm) -0.4300
Est. EPS (USD) (06/2015) -0.3820
Est. PEG Ratio -
Market Cap (M ILS) 679.07
Shares Outstanding (M) 69.28
30 Day Average Volume 90,269
Price/Book (mrq) 3.2926
Price/Sale (ttm) 436.3495
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PSTI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PSTI

Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.

Zami AbermanChief Executive OfficerYaky YanayPresident/COO
Boaz Gur-LavieCFO/Secretary
More Company Profile & Key Executives for PSTI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil